Effects of Metformin on Arterial Elasticity and Pro-inflammatory Markers in Black Diabetes Patients

Overview

Journal Health SA

Specialty Health Services

Date 2024 Jul 4

PMID 38962295

Authors

Tsakani L Rasakanya

Elzbieta Osuch

Affiliations

Soon will be listed here.

Abstract

Background: Pro-inflammatory markers are linked with the development and progression of type 2 diabetes mellitus and arterial stiffening. Pulse Wave Velocity (PWV) and Augmentation Index (Aix) are non-invasive standard markers of arterial elasticity and predictors of cardiovascular mortality and morbidity.

Aim: To investigate the effects of metformin alone and in combination with glimepiride on arterial elasticity, pro-inflammatory cytokines in black type 2 diabetes mellitus patients.

Settings: Participants were enrolled from Sefako Makgatho Health Sciences University community, Gauteng, South Africa.

Methods: PWV and Aix were measured using the AtCor SphygmoCor system (AtCor Medical, Inc., Sydney, Australia). Cytokines levels were measured using Multiplexing with Bio-Plex Pro™ human inflammation panel I assay. Treatment naïve type 2 diabetes participants were divided into two groups: metformin (M) ( = 10) and metformin glimepiride (MS) ( = 14). The study participants were followed up at 4 and 8 months after treatment initiation.

Results: In the M and MS, IL-1β increased significantly at four months (58.19 ± 0.03 pg/ml, 58.35 ± 0.30 pg/ml) when compared to baseline (33.05 ± 18.56 pg/ml, 34.79 ± 18.77 pg/ml) then decreased significantly at eight months (29.25 ± 11.64 pg/ml, 32.54 ± 14.26 pg/ml) when compared to four months (58.19 ± 0.03 pg/ml, 58.35 ± 0.3 pg/ml) ( < 0.05). There were no significant changes in PWV, Aix, IL-1ra, IL-2, IL-6, IL-8, TNF-α and hs-CRP levels at both treatment intervals.

Conclusion: Metformin alone or in combination with glimepiride did not improve arterial elasticity and did not reduce pro-inflammatory cytokines levels in T2DM black South African patients.

Contribution: The context-based knowledge generated by the current study is expected to enhance the continuum of care for T2DM patients.

References

Karbalaee-Hasani A, Khadive T, Eskandari M, Shahidi S, Mosavi M, Nejadebrahimi Z . Effect of Metformin on Circulating Levels of Inflammatory Markers in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Ann Pharmacother. 2021; 55(9):1096-1109. DOI: 10.1177/1060028020985303. View

Takemura Y, Osuga Y, Yoshino O, Hasegawa A, Hirata T, Hirota Y . Metformin suppresses interleukin (IL)-1beta-induced IL-8 production, aromatase activation, and proliferation of endometriotic stromal cells. J Clin Endocrinol Metab. 2007; 92(8):3213-8. DOI: 10.1210/jc.2006-2486. View

Rajbhandari J, Fernandez C, Agarwal M, Yeap B, Pappachan J . Diabetic heart disease: A clinical update. World J Diabetes. 2021; 12(4):383-406. PMC: 8040078. DOI: 10.4239/wjd.v12.i4.383. View

Dietrich T, Schaefer-Graf U, Fleck E, Graf K . Aortic stiffness, impaired fasting glucose, and aging. Hypertension. 2009; 55(1):18-20. DOI: 10.1161/HYPERTENSIONAHA.109.135897. View

Driessen J, de Vries F, van Onzenoort H, Schram M, van der Kallen C, Reesink K . Metformin use in type 2 diabetic patients is not associated with lower arterial stiffness: the Maastricht Study. J Hypertens. 2019; 37(2):365-371. DOI: 10.1097/HJH.0000000000001892. View

Matsumoto K, Sera Y, Abe Y, Tominaga T, Yeki Y, Miyake S . Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes. Diabetes Res Clin Pract. 2004; 64(3):225-8. DOI: 10.1016/j.diabres.2003.11.007. View

Osuch E, Du Plooy W, Du Plooy S, Bohmer L . Effect of perindopril on pulse-wave velocity and endothelin-1 in black hypertensive patients. Cardiovasc J Afr. 2012; 23(7):396-9. PMC: 3721803. DOI: 10.5830/CVJA-2012-043. View

Shargorodsky M, Omelchenko E, Matas Z, Boaz M, Gavish D . Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?. Cardiovasc Diabetol. 2012; 11:61. PMC: 3471007. DOI: 10.1186/1475-2840-11-61. View

Li J, Huang M, Shen X . The association of oxidative stress and pro-inflammatory cytokines in diabetic patients with hyperglycemic crisis. J Diabetes Complications. 2014; 28(5):662-6. DOI: 10.1016/j.jdiacomp.2014.06.008. View

10.

Araki T, Emoto M, Teramura M, Yokoyama H, Mori K, Hatsuda S . Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin. Metabolism. 2006; 55(8):996-1001. DOI: 10.1016/j.metabol.2006.03.008. View

11.

Rasakanya T, Osuch E . Arterial stiffness assessment in obese black South African patients. Cardiovasc J Afr. 2023; 35(1):7-11. DOI: 10.5830/CVJA-2022-064. View

12.

Misra D, Das S, Sahu P . Prevalence of inflammatory markers (high-sensitivity C-reactive protein, nuclear factor-κB, and adiponectin) in Indian patients with type 2 diabetes mellitus with and without macrovascular complications. Metab Syndr Relat Disord. 2012; 10(3):209-13. DOI: 10.1089/met.2011.0044. View

13.

Oh Y . Arterial stiffness and hypertension. Clin Hypertens. 2018; 24:17. PMC: 6271566. DOI: 10.1186/s40885-018-0102-8. View

14.

Cruz N, Sousa L, Sousa M, Pietrani N, Fernandes A, Gomes K . The linkage between inflammation and Type 2 diabetes mellitus. Diabetes Res Clin Pract. 2012; 99(2):85-92. DOI: 10.1016/j.diabres.2012.09.003. View

15.

Hyun B, Shin S, Lee A, Lee S, Song Y, Ha N . Metformin Down-regulates TNF-α Secretion via Suppression of Scavenger Receptors in Macrophages. Immune Netw. 2013; 13(4):123-32. PMC: 3759709. DOI: 10.4110/in.2013.13.4.123. View

16.

Daryabor G, Atashzar M, Kabelitz D, Meri S, Kalantar K . The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System. Front Immunol. 2020; 11:1582. PMC: 7387426. DOI: 10.3389/fimmu.2020.01582. View

17.

Lee H, Oh B . Aging and arterial stiffness. Circ J. 2010; 74(11):2257-62. DOI: 10.1253/circj.cj-10-0910. View

18.

Van Bortel L, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank J, De Backer T . Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012; 30(3):445-8. DOI: 10.1097/HJH.0b013e32834fa8b0. View

19.

Saisho Y . Metformin and Inflammation: Its Potential Beyond Glucose-lowering Effect. Endocr Metab Immune Disord Drug Targets. 2015; 15(3):196-205. DOI: 10.2174/1871530315666150316124019. View

20.

Lunder M, Janic M, Sabovic M . Treating Arterial Ageing in Patients with Diabetes: From Mechanisms to Effective Drugs. Int J Mol Sci. 2021; 22(6). PMC: 8001638. DOI: 10.3390/ijms22062796. View